Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen

  • Technology appraisal guidance
  • TA316
  • Published: 

Tools and resources

Implementation support

Research recommendations

Guidance into practice